 A ALIMENTARY TRACT AND METABOLISM
|
 A01 STOMATOLOGICAL PREPARATIONS
|
A02 DRUGS FOR ACID RELATED DISORDERS
|
A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
|
A04 ANTIEMETICS AND ANTINAUSEANTS
|
A05 BILE AND LIVER THERAPY
|
A06 DRUGS FOR CONSTIPATION
|
A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
|
A08 ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
|
A09 DIGESTIVES, INCL. ENZYMES
|
A10 DRUGS USED IN DIABETES
|
A10A INSULINS AND ANALOGUES
|
A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
|
A10BA Biguanides [DG:DG01684]
|
A10BB Sulfonylureas [DG:DG01734]
|
A10BC Sulfonamides (heterocyclic)
|
A10BD Combinations of oral blood glucose lowering drugs
|
A10BF Alpha glucosidase inhibitors [DG:DG01663]
|
A10BG Thiazolidinediones [DG:DG01683]
|
A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors [DG:DG01601]
|
A10BJ Glucagon-like peptide-1 (GLP-1) analogues [DG:DG01493]
|
A10BK Sodium-glucose co-transporter 2 (SGLT2) inhibitors [DG:DG01794]
|
A10BK01 Dapagliflozin [DG:DG00122]
|
A10BK02 Canagliflozin
|
A10BK03 Empagliflozin
|
 D10459 Empagliflozin (JAN/USAN/INN) <JP/US>
|
A10BK04 Ertugliflozin [DG:DG02836]
|
A10BK05 Ipragliflozin [DG:DG01248]
|
A10BK06 Sotagliflozin
|
A10BK07 Luseogliflozin
|
A10BK08 Bexagliflozin
|
A10BX Other blood glucose lowering drugs, excl. insulins
|
A10X OTHER DRUGS USED IN DIABETES
|
A11 VITAMINS
|
A12 MINERAL SUPPLEMENTS
|
A13 TONICS
|
A14 ANABOLIC AGENTS FOR SYSTEMIC USE
|
A15 APPETITE STIMULANTS
|
A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
|
|
B BLOOD AND BLOOD FORMING ORGANS
|
|
C CARDIOVASCULAR SYSTEM
|
|
D DERMATOLOGICALS
|
|
G GENITO URINARY SYSTEM AND SEX HORMONES
|
|
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
|
|
J ANTIINFECTIVES FOR SYSTEMIC USE
|
|
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
|
|
M MUSCULO-SKELETAL SYSTEM
|
|
N NERVOUS SYSTEM
|
|
P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
|
|
R RESPIRATORY SYSTEM
|
|
S SENSORY ORGANS
|
|
V VARIOUS
|
Anatomical Therapeutic Chemical (ATC) Classification